Search results
Results from the WOW.Com Content Network
[2] [10] In older people with psychosis as a result of dementia, it may increase the risk of death. [ 2 ] While atypical antipsychotics appear to have a lower rate of movement problems as compared to typical antipsychotics, risperidone has a high risk of movement problems among the atypicals.
Between May 2007 and April 2008, Dementia and Alzheimer's together accounted for 28% of atypical antipsychotic use in patients aged 65 or older. [46] The U.S. Food and Drug Administration requires that all atypical antipsychotics carry a black box warning that the medication has been associated with an increased risk of mortality in elderly ...
This is a list of adverse effects of risperidone. Risperidone , sold under the brand name Risperdal among others, is an antipsychotic . [ 1 ] It is used to treat schizophrenia , bipolar disorder , and irritability associated with autism .
[27] [4] It affects about 6% of people 65 years and older, [16] and women more often than men. [28] The disease is named after German psychiatrist and pathologist Alois Alzheimer, who first described it in 1906. [29] Alzheimer's financial burden on society is large, with an estimated global annual cost of US$1 trillion. [14]
Individuals may MUA antipsychotics for various reasons, including recreational purposes, self-medication, or attempting to alter their mental or emotional state.The most common forms of antipsychotic abuse may include non-prescribed use, which involves the use of antipsychotic medications without a valid legal prescription or the absence of medical supervision.
to treat behavioral disturbances in the elderly and psychosis in Alzheimer's patients. One study (RIS-USA-63), published in 1999, failed to show a statistically significant improvement in dementia patients taking Risperdal versus a placebo, but appeared to show some efficacy in treating psychosis and aggression in elderly patients.
[7] [8] There is evidence of clozapine, amisulpride, olanzapine, and risperidone being the most effective medications. However, a high proportion of studies of risperidone were undertaken by its manufacturer, Janssen-Cilag, and should be interpreted with this in mind. [9] In those on antipsychotics, continued use decreases the risk of relapse.
Ziprasidone is chemically similar to risperidone, [53] of which it is a structural analogue. [54] It was first synthesized in 1987 at the Pfizer central research campus in Groton, Connecticut. [55] Phase I trials started in 1995. [56] In 1998 ziprasidone was approved in Sweden.